Sector: Health Care
Director information for UNITEDHEALTH GROUP INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Charles Baker | President, National Collegiate Athletic Association; Director | 69 | ["Extensive public sector and health care leadership experience","Governor of the Commonwealth of Massachusetts","CEO of Harvard Pilgrim Health Care","Expertise in financial management and health policy","audit committee financial expert"] | ["Audit and Finance","Governance (Chair)","Public Responsibility","Audit and Finance Committee","Public Responsibility Committee"] | 2026 |
| F. William McNabb III | Former Chairman and CEO, The Vanguard Group, Inc.; Lead Independent Director | 68 | ["extensive global financial expertise","more than three-decade career","Chairman and CEO of The Vanguard Group, Inc.","understanding of financial markets","enterprise risk management","operational dynamics of scaling a complex, global organization"] | ["Compensation and Human Resources"] | 2026 |
| F. William McNabb III(2) | [] | [] | 2026 | ||
| John Noseworthy, M.D. | Former CEO and President, Mayo Clinic; Director | 74 | ["significant clinical and executive leadership expertise","tenure as President and CEO of Mayo Clinic","understanding of patient care delivery","medical research and complex, large-scale provider operations","background as a physician and clinical researcher","global perspective as a Health Governor of the World Economic Forum"] | ["Compensation and Human Resources","Health and Clinical Practice Policies","Health and Clinical Practice Policies Committee"] | 2026 |
| Kristen Gil | Former Vice President and Business Finance Officer, Alphabet, Inc.; Director | 54 | ["Extensive strategic, operational and financial leadership experience","Former Vice President and Business Finance Officer at Google","Directed financial strategy and business operations in innovation sectors","Roles at Marketron International and McKinsey & Company","Directorship experience at Proofpoint, Inc.","audit committee financial expert"] | ["Audit and Finance","Audit and Finance Committee"] | 2026 |
| Michele Hooper | Director; Chair | [] | ["Health and Clinical Practice Policies Committee","Public Responsibility Committee"] | 2026 | |
| Michele Hooper(1) | [] | [] | 2026 | ||
| Paul Garcia | Retired Chair and CEO, Global Payments, Inc.; Director | 73 | ["Significant executive leadership and technological expertise","Former Chairman and CEO of Global Payments Inc.","Former President and CEO of NaBanco","Experience at large, complex corporations with high transaction volumes","Directorship at major financial and data-driven public companies"] | ["Compensation and Human Resources","Public Responsibility","Public Responsibility Committee"] | 2026 |
| Scott Gottlieb, M.D. | Former Commissioner of the Food and Drug Administration; Director | 53 | ["Extensive clinical, regulatory and health care expertise","23rd Commissioner of the U.S. Food and Drug Administration","Current Senior Fellow at the American Enterprise Institute","Venture capital experience at New Enterprise Associates","Understanding of national health care policy, patient care and complex regulatory environments"] | ["Health and Clinical Practice Policies","Public Responsibility","Health and Clinical Practice Policies Committee","Public Responsibility Committee"] | 2026 |
| Stephen Hemsley | Chair and CEO, UnitedHealth Group | 73 | ["vast company and health care institutional knowledge","strategic vision","foundational financial expertise as a former Managing Partner and CFO at Arthur Andersen","understanding of complex enterprise and its culture","oversight of corporate strategy and enterprise-wide execution"] | [] | 2026 |
| Timothy Flynn | Former Chair, KPMG International; Director | 69 | ["expertise in financial reporting","audit and enterprise risk management","experience with large, complex public companies","Chairman of KPMG International","CEO of KPMG LLP","directorship experience at major public companies including JP Morgan","audit committee financial expert"] | ["Audit and Finance (Chair)","Governance","Public Responsibility","Audit and Finance Committee","Public Responsibility Committee"] | 2026 |
| Valerie Montgomery Rice, M.D. | President and CEO, Morehouse School of Medicine; Director; Chair | 64 | ["Significant clinical, academic, management and public health leadership experience","President and Chief Executive Officer of the Morehouse School of Medicine","Renowned physician, medical researcher and institutional leader"] | ["Compensation and Human Resources","Health and Clinical Practice Policies (Chair)","Health and Clinical Practice Policies Committee"] | 2026 |
